More than six million mBioCoV-19 qRT-PCR Kits were used to fight the pandemic
mBioCOv-19 is a local multiplex qRT-PCR test kit born out of a nationalistic desire to collaborate in tackling the Covid-19 pandemic in Indonesia.
A collaboration result between Nusantics and the Indonesian National Research and Innovation Agency (BRIN), mBioCOv-19, is designed to detect conserved target genes to detect all COVID-19 strains in Indonesia with certainty. This is validated by independent laboratories and has a specificity of 100% and a sensitivity above 95%.